About TRB Chemedica

TRB Chemedica is a medium-sized Swiss
pharmaceutical company, with a focus on research,
development and marketing of innovative niche
products in specific therapeutic areas, including
rheumatology, ophthalmology and neurology. The
company markets a range of ethical pharmaceuticals
and medical devices, most of which are patented, in
more than 40 countries worldwide.

TRB Chemedica is a growing organisation currently
employing more than 500 people worldwide. The
international headquarters are located in Geneva,
Switzerland, with subsidiaries in Argentina, Austria,
Brazil, France, Germany, Hong Kong, Hungary,
Malaysia, Mexico, Poland, Singapore, Switzerland,
Thailand and the United Kingdom. The company's
plan for the future is to increase the in-house
manufacturing capacity, continue to develop the
subsidiaries, and extend the distribution network to
cover more countries around the world.
TRB Chemedica is committed to growth in the
international arena.

The mission of TRB Chemedica Group is to continue
to discover, develop and market innovative and
patented pharmaceutical products and medical
devices in niche therapeutic areas, particularly in
rheumatology, ophthalmology and neurology.

TRB Chemedica (UK) Ltd which is based at the Science Park on the Keele University campus, was established in January 2002 as the British subsidiary of the Swiss healthcare group. It is responsible for marketing the rheumatology and ophthalmology product ranges in the UK and Ireland.